Kalo Gold Ret. on equity
What is the Ret. on equity of Kalo Gold?
The Ret. on equity of Kalo Gold Holdings Corp. is -427.81%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Materials sector on TSXV compared to Kalo Gold
What does Kalo Gold do?
Kalo Gold Holdings Corp. engages in exploration of minerals. Its principal project is Vatu Aurum Gold Project located in Fiji's North Island, Vanua Levu. It holds two mineral exploration licenses covering over 36,700 hectares of land and gold deposits in the Southwest Pacific Ring of Fire. The company was incorporated in 2020 and is based in Vancouver, Canada.
Companies with ret. on equity similar to Kalo Gold
- Novabay Pharmaceuticals Inc has Ret. on equity of -431.13%
- Core Gold has Ret. on equity of -430.83%
- Alnylam Pharmaceuticals has Ret. on equity of -430.74%
- Alnylam Pharmaceuticals has Ret. on equity of -430.74%
- Spectur has Ret. on equity of -430.03%
- Midas Gold has Ret. on equity of -428.98%
- Kalo Gold has Ret. on equity of -427.81%
- The Orissa Minerals Development has Ret. on equity of -426.93%
- Blackwolf Copper and Gold has Ret. on equity of -426.89%
- Zargon Oil & Gas has Ret. on equity of -426.68%
- Relevium Technologies has Ret. on equity of -426.47%
- Lianluo Smart Ltd has Ret. on equity of -425.53%
- Avenue Therapeutics Inc has Ret. on equity of -424.15%